K2 Principal Fund’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.53M | Sell |
|
|||||
|
2025
Q1 | $6.11M | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $1.74M | Sell |
|
|||||
|
2024
Q2 | $20.9M | Buy |
|
|||||
|
2024
Q1 | $22.7M | Sell |
|
|||||
|
2023
Q4 | $16.7M | Buy |
|
|||||
|
2023
Q3 | $9.65M | Buy |
|
|||||
|
2023
Q2 | $8.52M | Sell |
|
|||||
|
2023
Q1 | $17.5M | Sell |
|
|||||
|
2022
Q4 | $24.5M | Sell |
|
|||||
|
2022
Q3 | $16.9M | Buy |
|
|||||
|
2022
Q2 | $6.54M | Buy |
|